Cryptopolitan Report: A Pill To Help Dogs Live Longer Is Near. Half Our Readers Are Ready To Sign Up 

Loyal, a San Francisco startup, has moved its dog pill LOY-002 through two of three technical reviews required for the FDA Center for Veterinary Medicine’s expanded conditional approval route, with a manufacturing review expected in 2027. The daily beef-flavored drug is intended for dogs at least 10 years old and weighing at least 14 pounds. Conditional approval would mean regulators consider it safe and reasonably likely to be effective, not that it extends lifespan; that question is being tested in STAY, a four-year, double-blind, placebo-controlled trial of 1,300 senior dogs at 70 U.S. veterinary clinics. In a newsletter poll, 50% of readers said they would give the drug to their dog right away after approval.